Skip to main content
Clinical Trials/CTRI/2021/03/031852
CTRI/2021/03/031852
Completed
Phase 4

A prospective, single arm, post market clinical follow-up of Intra Cath-2 (I.V Cannula) to explore safety and performance in Indian population.

Romsons Scientific and Surgical Industries Pvt Ltd0 sites100 target enrollmentTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Not specified
Sponsor
Romsons Scientific and Surgical Industries Pvt Ltd
Enrollment
100
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
April 27, 2024
Last Updated
last year
Study Type
Pms

Investigators

Sponsor
Romsons Scientific and Surgical Industries Pvt Ltd

Eligibility Criteria

Inclusion Criteria

  • 1\.Males and Females above 18 year expected to require intravenous peripheral infusion therapy.
  • 2\.Subject who can provide informed consent form in writing and medically in a position to undergo consent and screening process.
  • 3\.The subject is willing and able to comply with the requirement of the follow\-up.

Exclusion Criteria

  • 1\.Subject who present with medical emergency, where treatment is more priority than the informed consent process.
  • 2\.Subject, who cannot provide informed consent such as unconscious, mentally challenged subject, etc.
  • 3\.Allergy with any of the material of Intra Cath\-2 (I.V Cannula) and its component.
  • 4\.Subject who is pregnant or breastfeeding.
  • 5\.Subject is of childbearing potential and has a positive pregnancy test since admission to the hospital.
  • 6\.Participation in another research study involving an active investigation within 30 days prior to consent.

Outcomes

Primary Outcomes

Not specified

Similar Trials